| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/28/2004 | CN1159006C Application of bilirubin and its derivative as preparation of resisting influenza viurs A1 type |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | US6767900 Phosphonate nucleotide compound |
| 07/27/2004 | US6767561 Plant extracts as antiproliferative, viricides and antiparasitic agents |
| 07/27/2004 | US6767557 Taste masked pharmaceutical compositions |
| 07/27/2004 | US6767549 Ionic polymers as anti-infective agents |
| 07/27/2004 | US6767545 Composition for use in treating or preventing infection by pseudomonas aeruginosa comprising a p. aeruginosa pilin protein having an n-terminal peptide region modified to prevent self assembly of the peptide |
| 07/27/2004 | US6767539 Method of treating viral hemorrhagic fever |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2358395C Extended release formulations of erythromycin derivatives |
| 07/27/2004 | CA2331261C 2"-deoxy hygromycin derivatives |
| 07/27/2004 | CA2320233C Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/27/2004 | CA2103072C Pleuromutilin derivatives |
| 07/24/2004 | CA2455701A1 The use of cross-protection to identify novel vaccine candidates for infectious agents |
| 07/24/2004 | CA2428744A1 Inhibition of lysozyme in treating sepsis-induced myocardial dysfunction |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060919A1 Agonist antibody against heteroreceptor |
| 07/22/2004 | WO2004060889A1 5-thiazole substituted 2-pyrrolidine-carboxylic acids |
| 07/22/2004 | WO2004060886A1 (3r, 4r)-4-'3-(s)-hydroxy-3-(6-mehtoxyquinolin-4-yl) propyli [-1-'2-(2-thienylthio) ethyl ]ipiperidine-3-carboxylic acid crystalline form |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004060873A1 Novel 5-hydroxyindole-3-carboxylate derivatives |
| 07/22/2004 | WO2004060860A2 Method for inhibiting the replication of herpes viruses |
| 07/22/2004 | WO2004060487A2 Composition for the treatment of hiv or aids |
| 07/22/2004 | WO2004060402A1 Method and material for specific proliferation promotion of lymphocyte sub-populations by means of a combination of an immunomodulator with a non-water-soluble natural product and a carrier |
| 07/22/2004 | WO2004060397A1 Antimicrobial composition for local use on mucosal membranes and skin |
| 07/22/2004 | WO2004060379A2 Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications |
| 07/22/2004 | WO2004060370A1 Treatment of hiv infection through combined administration of tipranavir and capravirine |
| 07/22/2004 | WO2004060360A1 Use of active ingredients for the prophylaxis and/or therapy of viral diseases |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004043339A3 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 07/22/2004 | WO2004033417A3 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 07/22/2004 | WO2004014936A3 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 07/22/2004 | WO2004006843A3 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 07/22/2004 | WO2004006835A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 07/22/2004 | WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 07/22/2004 | WO2003082184A3 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/22/2004 | WO2003075843A3 Multiple and multivalent dna vaccines in ovo |
| 07/22/2004 | WO2003072757A3 Nucleotide mimics and their prodrugs |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143114 useful for synthesis of non-natural oligonucleotide analogues which exhibit excellent anti-sense or anti-gene activity and in vivo stability |
| 07/22/2004 | US20040143001 Using photodynamic compound; bactericides, fungicides, viricides; killing microorganisms |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142985 Heterocyclic compounds useful to treat HCV |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142981 Sterilization, antiseptics for bacteria infections |
| 07/22/2004 | US20040142980 Viricides; hepatitis virus infections |
| 07/22/2004 | US20040142977 4-Substituted-picolinic acid amide derivatives useful as fungicides |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142971 Benzothiophene compounds having antiinfective activity |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142960 Yohimbine as immunobiologically active agent |
| 07/22/2004 | US20040142957 Bactericides; photostability, waterproofing |
| 07/22/2004 | US20040142941 Therapeutic compounds |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142928 particularly against herpes viruses |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142883 prolonged serum half-life to permit treatment regimens of about once every 5-7 days or longer, while retaining antibacterial properties in vivo |
| 07/22/2004 | US20040142882 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 07/22/2004 | US20040142878 N-cycloalkylglycines as HIV protease inhibitors |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142342 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions |
| 07/22/2004 | US20040142317 Use of amino acid transporter atbo,+ as a delivery system for drugs and prodrugs |
| 07/22/2004 | US20040142029 cellulose polymer, a methacrylic polymer and an active ingredient homogeniously distributed in a molecular state in an atomized matrix; also contains an organic base or an alkaline salt; and an adsorbent |
| 07/22/2004 | US20040142002 Recombinant poxvirus |
| 07/22/2004 | US20040142000 Immune activator |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141980 Recombinant antibodies against infectious bursal disease virus (ibdv) |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2551760A1 Antimicrobial composition for local use on mucosal membranes and skin |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | CA2509731A1 Treatment of hiv infection through combined administration of tipranavir and capravirine |
| 07/21/2004 | EP1439227A1 HPV-E6-specific siRNAs for the treatment of HPV-related tumors |
| 07/21/2004 | EP1439187A1 O2-Arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 07/21/2004 | EP1439178A1 HETEROCYCLIC COMPOUNDS, OXAZOLE DERIVATIVES, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438970A2 Methods for inhibiting HIV associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 07/21/2004 | EP1438942A1 An otorhinological drug delivery device |
| 07/21/2004 | EP1438409A1 Use of a double strand ribonucleic acid for treating an infection with a positive-strand rna-virus |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |